Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haopeng Sun

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2013
Indenoisoquinoline derivatives as topoisomerase I inhibitors that suppress angiogenesis by affecting the HIF signaling pathwayXiaoli Xu, Fang Liu, Shengmiao Zhang, et al.
ACS Chemical Neuroscience|October 2, 2024
Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?Baichen Xiong, Zuoaoyun Song, Leyan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2015
Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potencyYue Wu, Mingyang Hu, Li Yang, et al.
Expert Opinion on Therapeutic Patents|March 29, 2017
Gamma secretase inhibitors: a patent review (2013 - 2015)Kai Gu, Qi Li, Hongzhi Lin, et al.
Bioorganic Chemistry|August 24, 2021
Computational design of binder as the LC3-p62 protein-protein interactionWeiping Lyu, Qihang Li, Yingming Wang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2026
2-(Diphenylphosphinoyl)acetyl Group Enabled Divergent Synthesis of 2'-O-Acetyl Phenylethanoid GlycosidesKai Liu, Longxing Tang, Wenyi Peng, et al.
Bioorganic & Medicinal Chemistry|May 10, 2025
Dual inhibitors of butyrylcholinesterase and histone deacetylase 6 for the treatment of Alzheimer's disease: design, synthesis, and biological evaluationBingbing Lv, Zhenqi Wang, Qinjie Wang, et al.
Dose-Response : a Publication of International Hormesis Society|July 9, 2020
Discovery of a Selective 6-Hydroxy-1, 4-Diazepan-2-one Containing Butyrylcholinesterase Inhibitor by Virtual Screening and MM-GBSA RescoringYou Zhou, Yanyu Hu, Xin Lu, et al.
Current Pharmaceutical Design|August 14, 2018
The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug DiscoveryXin Lu, Hongyu Yang, Yao Chen, et al.
Bioorganic & Medicinal Chemistry|July 2, 2018
Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's diseaseYifan Zhao, Feng Ye, Jian Xu, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2013
Indenoisoquinoline derivatives as topoisomerase I inhibitors that suppress angiogenesis by affecting the HIF signaling pathwayXiaoli Xu, Fang Liu, Shengmiao Zhang, et al.
ACS Chemical Neuroscience|October 2, 2024
Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?Baichen Xiong, Zuoaoyun Song, Leyan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2015
Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potencyYue Wu, Mingyang Hu, Li Yang, et al.
Expert Opinion on Therapeutic Patents|March 29, 2017
Gamma secretase inhibitors: a patent review (2013 - 2015)Kai Gu, Qi Li, Hongzhi Lin, et al.
Bioorganic Chemistry|August 24, 2021
Computational design of binder as the LC3-p62 protein-protein interactionWeiping Lyu, Qihang Li, Yingming Wang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2026
2-(Diphenylphosphinoyl)acetyl Group Enabled Divergent Synthesis of 2'-O-Acetyl Phenylethanoid GlycosidesKai Liu, Longxing Tang, Wenyi Peng, et al.
Bioorganic & Medicinal Chemistry|May 10, 2025
Dual inhibitors of butyrylcholinesterase and histone deacetylase 6 for the treatment of Alzheimer's disease: design, synthesis, and biological evaluationBingbing Lv, Zhenqi Wang, Qinjie Wang, et al.
Dose-Response : a Publication of International Hormesis Society|July 9, 2020
Discovery of a Selective 6-Hydroxy-1, 4-Diazepan-2-one Containing Butyrylcholinesterase Inhibitor by Virtual Screening and MM-GBSA RescoringYou Zhou, Yanyu Hu, Xin Lu, et al.
Current Pharmaceutical Design|August 14, 2018
The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug DiscoveryXin Lu, Hongyu Yang, Yao Chen, et al.
Bioorganic & Medicinal Chemistry|July 2, 2018
Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's diseaseYifan Zhao, Feng Ye, Jian Xu, et al.
Pageof 17